CBD Oil for Parkinson’s Disease

  • Emerging research suggests that CBD may offer therapeutic benefits for those living with Parkinson’s.
  • CBD may play more of a preventive role in Parkinson’s disease than a therapeutic one.
  • Studies indicate, however, that CBD may also improve quality of life for Parkinson’s disease patients.
  • Some Parkinson’s patients find that CBD is more effective when teamed with THC.
  • Studies performed on rodents demonstrate the beneficial effects of CBD on treating or preventing motor abnormalities.

Parkinson’s disease (PD) is a neurodegenerative disease caused by the loss of dopamine-producing brain cells. Dopamine cells help to control movement and also influence mood. Many individuals living with Parkinson’s experience tremors, stiffness, or slowness of movement and may have depression or anxiety. The symptoms of the disease can also cause pain. The condition is both chronic and progressive.

There is still no cure for PD, but symptoms can be managed with surgery or medications that substitute or increase dopamine. Some of these medications can cause unpleasant short term-side effects, however, such as dizziness, nausea, or even compulsive behaviors. Problematically, the benefits offered by these medicines can wane or become unstable over time.

Emerging research suggests that CBD may offer therapeutic benefits for those living with Parkinson’s. What type of alleviation might it offer?

Photo by Gina Coleman/Weedmaps News

Overview of the Research 

CBD has anti-inflammatory, neuroprotective, and antioxidative effects. Both oxidative stress and inflammation play a role in Parkinson’s and all movement disorders to some extent. CBD also has anxiolytic, or anti-anxiety, properties, which may help patients who experience anxiety or depression along with PD.

The few human studies that have evaluated CBD as a treatment for PD have focused on its potential to help with non-motor symptoms, such as psychotic symptoms, well-being, and sleep disorders. There is research in animal models, however, indicating that CBD may also help with the management of motor symptoms. 

One 2018 review of existing research published in Frontiers in Pharmacology on CBD for Parkinson’s disease suggests that CBD may play more of a preventive role in the illness rather than a therapeutic one.

Studies on CBD for Parkinson’s Disease

A 2014 study on human participants published by Sage in the Journal of Psychopharmacology indicated that CBD might improve the quality of life of PD patients. The study’s authors found improvements in functioning and well-being among patients treated with 300 milligrams of CBD daily over six weeks, and pointed to its anxiolytic, antidepressant, and sedative properties as possibly explaining these improvements. 

However, the study authors failed to find a statistically significant benefit of CBD for motor symptoms, nor was there evidence that CBD provided neuroprotective benefits despite evidence of neuroprotection in animal models. The authors did acknowledge that the study used a small sample (21 patients in total) and that longer tracking may be required for neuroprotective benefits to become apparent.

A 2008 pilot study, also published in the Journal of Psychopharmacology, evaluated the efficacy, tolerability, and safety of CBD on Parkinson’s disease patients with psychotic symptoms. Psychosis affects almost one-third of PD patients in the latter stages of the illness. Four men and two women who had had psychosis for at least three months received pure CBD in varying doses (beginning with 150 milligrams per day) for four weeks in conjunction with their usual therapy. 

Scales, questionnaires, and interviews showed that the CBD treatment significantly improved thinking disorders, and also significantly decreased sleep disturbances, hallucinations, and delusions. Although CBD did not affect motor function in a statistically significant way, patients seemed to show some improvement. Patients tolerated the CBD treatment well, without experiencing adverse effects.

Photo by Gina Coleman/Weedmaps News

A 2014 case report published in the Journal of Clinical Pharmacy and Therapeutics, investigated CBD as a treatment for REM sleep behavior disorder in four Parkinson’s disease patients. Three patients received 75 milligrams of CBD per day, and one received 300 milligrams daily. All four patients received CBD for six weeks.

Nightmares, agitation, and aggressive behavior promptly and significantly reduced in the case of one man and completely ceased in the other three cases over the six weeks. However, after the treatment was interrupted, symptoms returned with the same frequency and intensity. 

Patient Perspectives

In Reddit forums, patients living with PD discuss their experiences of using CBD as a treatment for symptoms associated with the condition.

One contributor noted that CBD seemed to assist motor function to some degree.

“We’ve been trying drops under the tongue for the last couple of weeks with my father to help him sleep at night. Not used consistently enough to see if it’s helping yet, but my mother notices some reduction in his hand tremors.

Photo by Gina Coleman/Weedmaps News

Another contributor found that CBD was more effective when teamed with THC, and believed it was beneficial to start with a conservative dose and gradually titrate up.

“I don’t use CBD for my tremors (they are very minor unless I’m in a lot of pain or stressed) but I use it for muscle rigidity and pain. I personally do not find CBD as effective as THC, but I do use both. It’s ALWAYS safer to start with a smaller dose then work your way up, even just CBD, especially with edibles! If you aren’t careful it can hit you really hard and make you feel a lot worse. And I mean a LOT worse! Been there myself and now I’m really careful about dosing.

An individual living with Parkinson’s disease shared his observations on a forum maintained by Parkinson.org after using CBD (without THC) for a month:

“Over the course of the past month, I’ve lost some of the super benefits that I thought I was getting during the first week, but the fact remains that a noticeable level of improvement has persisted. I really need help with anxiety, agitation, anger issues, autonomic nerve deficiencies,  and many other non-movement type things. I think and hope that the CBD oil is helping.”  

Expert Views 

Fernanda F. Peres is the leading author on a 2018 review of CBD as a treatment for Parkinson’s disease and other movement disorders, published in Frontiers in Pharmacology.

Peres is convinced that CBD holds strong potential in the treatment of PD.

“We have data pointing to CBD’s beneficial effects on non-motor symptoms. Using CBD in addition to antiparkinsonian medications is a future possibility, in my opinion.”

Peres points out that first-line medications for PD, such as carbidopa-levodopa, increase dopaminergic neurotransmission, which improves the motor symptoms but can lead to significant adverse effects such as psychotic symptoms or involuntary movements. 

“These medicines can diminish the motor impairments, but it does not stop or prevent the dopaminergic neurodegeneration that is the basis of PD,” she added.

Photo by Gina Coleman/Weedmaps News

CBD, on the other hand only causes mild side effects, such as fatigue or a dry mouth, in some individuals. CBD could also help to prevent or slow the progression of PD. Although there is currently a lack of clinical evidence in human studies, Peres believes that earlier diagnosis of Parkinson’s disease will enable the neuroprotective properties of CBD to work better. 

She points to the studies performed on rodents that demonstrate the beneficial effects of CBD on treating or preventing motor abnormalities and emphasizes that the difference between the human and animal studies is that PD is diagnosed later in human participants, compared with animal models in which PD is induced.

“Currently, when PD is diagnosed about 60% of dopaminergic neurons are already lost,” Peres explained to Weedmaps News. 

“Considering the neuroprotective effects of CBD, it might not be beneficial after extensive neurodegeneration. We speculate that future improvements in PD diagnosis criteria will lead to earlier diagnosis and will expand CBD’s benefits for PD patients. CBD is a molecule with multiple mechanisms of action, not all of them fully elucidated.”

The Bottom Line

While there is evidence that CBD may improve quality of life and sleep in Parkinson’s disease patients, more research is needed to understand if CBD may help prevent or decelerate neurodegeneration leading to motor abnormalities. 

 

Featured Image: Photo by Gina Coleman/Weedmaps News